You just read:

Initiation of a Phase 2 Multicenter Study of 18F-APN-1607, a Novel Diagnostic PET Imaging Tracer for the Characterization of Tau Burden in Alzheimer's Disease

News provided by

APRINOIA Therapeutics Inc.

Nov 21, 2019, 10:00 ET